Caveolin-1 in oncogenic transformation, cancer, and metastasis

被引:448
作者
Williams, TM
Lisanti, MP
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2005年 / 288卷 / 03期
关键词
caveolae; cellular signaling; tumor formation; cell invasiveness;
D O I
10.1152/ajpcell.00458.2004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Caveolae are 50- to 100-nm omega-shaped invaginations of the plasma membrane that function as regulators of signal transduction. Caveolins are a class of oligomeric structural proteins that are both necessary and sufficient for caveolae formation. Interestingly, caveolin-1 has been implicated in the pathogenesis of oncogenic cell transformation, tumorigenesis, and metastasis. Here, we review the available experimental evidence ( gleaned from cultured cells, animal models, and human tumor samples) that caveolin-1 (Cav-1) functions as a "tumor and/or metastasis modifier gene." Genetic evidence from the study of Cav-1( -/-) null mice and human breast cancer mutations [CAV-1 (P132L)] supports the idea that caveolin-1 normally functions as a negative regulator of cell transformation and mammary tumorigenesis. In contrast, caveolin-1 may function as a tumor promoter in prostate cancers. We discuss possible molecular mechanisms to explain these intriguing, seemingly opposing, findings. More specifically, caveolin-1 phosphorylation ( at Tyr14 and Ser80) and mutations ( P132L) may override or inactivate the growth inhibitory activity of the caveolin-scaffolding domain ( residues 82 - 101).
引用
收藏
页码:C494 / C506
页数:13
相关论文
共 136 条
[1]  
Aldred MA, 2003, CANCER RES, V63, P2864
[2]   Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains [J].
Annabi, B ;
Lachambre, MP ;
Bousquet-Gagnon, N ;
Pagé, M ;
Gingras, D ;
Béliveau, R .
BIOCHEMICAL JOURNAL, 2001, 353 :547-553
[3]   Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to α-folate receptor overexpression [J].
Bagnoli, M ;
Tomassetti, A ;
Figini, M ;
Flati, S ;
Dolo, V ;
Canevari, S ;
Miotti, S .
ONCOGENE, 2000, 19 (41) :4754-4763
[4]   Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells [J].
Bélanger, MM ;
Gaudreau, M ;
Roussel, É ;
Couet, J .
CANCER BIOLOGY & THERAPY, 2004, 3 (10) :954-959
[5]  
Bender FC, 2000, CANCER RES, V60, P5870
[6]   Role of transforming growth factor β in breast carcinogenesis [J].
Benson, JR .
LANCET ONCOLOGY, 2004, 5 (04) :229-239
[7]   Differential gene expression in metastasizing cells shed from kidney tumors [J].
Bockhorn, M ;
Roberge, S ;
Sousa, C ;
Jain, RK ;
Munn, LL .
CANCER RESEARCH, 2004, 64 (07) :2469-2473
[8]   Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma [J].
Campbell, L ;
Gumbleton, M ;
Griffiths, DFR .
BRITISH JOURNAL OF CANCER, 2003, 89 (10) :1909-1913
[9]   Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation [J].
Capozza, F ;
Williams, TM ;
Schubert, W ;
McClain, S ;
Bouzahzah, B ;
Sotgia, F ;
Lisanti, MP .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) :2029-2039
[10]   Caveolin expression in adult renal tumors [J].
Carrion, R ;
Morgan, BE ;
Tannenbaum, M ;
Salup, R ;
Morgan, MB .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (03) :191-196